AC Immune SA
NASDAQ:ACIU
AC Immune SA
Depreciation & Amortization
AC Immune SA
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AC Immune SA
NASDAQ:ACIU
|
Depreciation & Amortization
CHf2.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Depreciation & Amortization
$1.2m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Depreciation & Amortization
$19.6m
|
CAGR 3-Years
26%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Depreciation & Amortization
CHf1.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Depreciation & Amortization
CHf19m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Depreciation & Amortization
CHf2.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's Depreciation & Amortization?
Depreciation & Amortization
2.2m
CHF
Based on the financial report for Mar 31, 2024, AC Immune SA's Depreciation & Amortization amounts to 2.2m CHF.
What is AC Immune SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
14%
Over the last year, the Depreciation & Amortization growth was -6%. The average annual Depreciation & Amortization growth rates for AC Immune SA have been 3% over the past three years , 14% over the past five years .